We all know that consumers are online to research the products they are planning to buy. This also applies to health care and medicine. According to the Princeton Research Association, 80% of adult Internet researchers [about 93 million Americans] searched online for at least one of 16 major health topics.
Blogs are an online platform that allows pharmaceutical companies to share product information more frequently than regular websites. This information sharing can be done in a controlled environment to ensure compliance when required. Patient education and information articles provide value to online viewers who can view insights on specific health topics on the Internet.
Before a pharmaceutical company decides to invest in a blog, it must take time to do research, understand who the target audience is, find the demand, and then find opportunities to fill the gaps in the information that may seem inadequate or difficult to obtain.
Yes, if you want to know, there is a FDA [Food and Drug Administration] restriction and a content guide for a pharmaceutical-focused blog for any pharmaceutical website. Direct Consumer-Oriented [DTC] regulations must be followed. E.g. Information about the product must be provided in a balanced manner and the risks and benefits of the product should be measured equally.
With these limitations in mind, pharmaceutical companies can choose from
Brand from
Either from
No brand blog from
.
1. Brand blog
Brand blogging increases brand awareness, positioning the company as an activist in the disease field, improving search engine rankings for keyword phrases, and helping target communities understand specific disease states or products. Here, information seekers can find information and allow influential people to share content in online forums.
However, brand blogs are flawed. These blogs need to contain important safety information [ISI], which is important, but can be confusing and distracting. It also reduces the trust of readers because the site is just another marketing path.
2. No brand blog
Unbranded blogs have fewer restrictions on content creation and may add more value. Such blogs provide a platform for open discussion of disease states, lifestyle conversations, and stories that are authorized to be shared within the community. This is a more realistic, unbranded storytelling that can hear the voice of the organization, influence online sentiment and build keyword traffic.
Here are a few examples of unbranded pharmaceutical blogs.
1. Sanofi discusses diabetes
2. Your epileptic partner
Blogs have also built followers because they work perfectly with social media platforms like Twitter and Facebook. Every post done on the blog sends an alert to its subscribers via email, and the social network receives notifications for each posted blog post, which helps increase network traffic.
A well-maintained blog can give readers confidence in you, your company and your brand. It helps to establish strong connections with readers and encourages viewers to return relevant information. The blogging process adds fresh content to your pages and allows information to be shared within the social community. This leads to the introduction of the site, which increases credibility and improves search engine rankings.
Blogging is more than just a hobby. It has serious commercial potential and can appeal to large pharmaceutical companies. For today's businesses, it's an essential tool with endless functionality that should be part of a sound marketing plan.
Orignal From: Blog: A powerful tool for pharmaceutical companies with unlimited possibilities
No comments:
Post a Comment